All articles by Shalini Nair

Turner & Townsend chosen for BAESL MRO factory in Beijing

UK-based construction company Turner & Townsend has been appointed as the project management service provider for the new maintenance, repair,…
Sanofi enlists Thread as decentralised clinical trial provider in new deal

French multinational pharmaceutical company Sanofi has enlisted Thread as a global decentrialised clinical trial provider under a five-year collaboration deal.…
Ukrainian ports pause commercial shipping amid Russian invasion

Commercial shipping at Ukrainian ports has been put on hold by the country’s military following the invasion by Russian forces.…
Bio-Thera Solutions begins dosing in Phase I trial of cancer drug

China-based commercial stage pharmaceutical firm Bio-Thera Solutions has commenced dosing in the Phase I clinical trial of BAT6005, a monoclonal…
Philippines approves Sputnik V Covid-19 vaccine for emergency use

The Food and Drug Administration of the Philippines has approved Sputnik V Covid-19 vaccine for emergency use, as the country…

Tonix reports positive Covid-19 vaccine results in TNX-1800-dosed primates

Tonix Pharmaceuticals has reported preliminary positive results after vaccinating primates with TNX-1800, a live modified horsepox virus vaccine for percutaneous…
Altimmune Covid-19 vaccine candidate prevents SARS-CoV-2 disease in studies

US-based Altimmune has reported that additional preclinical data on its single dose intranasal Covid-19 vaccine candidate, AdCOVID, showed 100% protection…
WHO issues EUL for J&J’s single-shot Covid-19 vaccine

The World Health Organization (WHO) has issued Emergency Use Listing (EUL) for the single-dose Covid-19 vaccine, developed by the Janssen…
AstraZeneca and Amgen report positive results from NAVIGATOR trial

AstraZeneca and Amgen have reported positive results from the NAVIGATOR Phase III trial for Tezepelumab, a potential drug in treating…
Five Prime Therapeutics reports positive results from Phase II FIGHT trial

Five Prime Therapeutics, a clinical-stage biotechnology company, has reported positive topline results from the global, randomised, double-blind placebo-controlled Phase II…